NeOnc Technologies Holdings, Inc. reported that as of August 13, 2025, it identified an overstatement in its share-based compensation for the quarter ending March 31, 2025, due to a calculation error regarding 1,486,667 restricted stock units that were inaccurately assumed to be fully vested; this report indicates that the previous financial statements should no longer be relied upon and will be restated in the upcoming quarterly filing.